Home Cart Sign in  
Chemical Structure| 536-43-6 Chemical Structure| 536-43-6

Structure of Dyclonine HCl
CAS No.: 536-43-6

Chemical Structure| 536-43-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dyclonine HCl is the HCl form of dyclonine which can reversibly bind to activated sodium channels on the neuronal membrane. It is an anaesthetic found in sucrets.

Synonyms: Dyclocaine hydrochloride; Dyclonine (hydrochloride); Tanaclone

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dyclonine HCl

CAS No. :536-43-6
Formula : C18H28ClNO2
M.W : 325.87
SMILES Code : O=C(C1=CC=C(OCCCC)C=C1)CCN2CCCCC2.[H]Cl
Synonyms :
Dyclocaine hydrochloride; Dyclonine (hydrochloride); Tanaclone
MDL No. :MFCD00035386
InChI Key :KNZADIMHVBBPOA-UHFFFAOYSA-N
Pubchem ID :68304

Safety of Dyclonine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
mouse epidermal keratinocytes 5 and 30 μM inhibition of endogenous TRPV3 channel activity Elife. 2021 Apr 20;10:e68128
HEK 293T cells 5 and 10 μM inhibition of TRPV3 currents Elife. 2021 Apr 20;10:e68128
HEK 293 GnTI− cells 29.8 ± 5.3 µM To study the inhibitory effect of Dyclonine on TRPV3-mediated Ca2+ uptake Nat Commun. 2022 May 19;13(1):2795
MDA-MB-231 cells 30 μg/ml 48 hours enhance the cytotoxic effects of MG132 on breast cancer cells Int J Mol Med. 2009 Feb;23(2):205-9
BT549 cells 30 μg/ml 48 hours enhance the cytotoxic effects of MG132 on breast cancer cells Int J Mol Med. 2009 Feb;23(2):205-9
HeLa cells 1.25–10 μM 24 hours To evaluate the effect of Dyclonine on ARE-luciferase reporter gene expression. Results showed Dyclonine dose-dependently increased ARE-luciferase activity. Hum Mol Genet. 2014 Dec 20;23(25):6848-62
FA patient lymphoblasts 0.3–10 μM 48 hours To assess the effect of Dyclonine on FXN protein levels in FA patient lymphoblasts. Results showed Dyclonine dose-dependently increased FXN protein expression. Hum Mol Genet. 2014 Dec 20;23(25):6848-62
oligodendrocyte progenitor cells (OPCs) 750 nM 3 days cell-autonomously fostered OPC differentiation into MBP+ oligodendrocytes Nat Commun. 2024 Nov 13;15(1):9837
neural progenitor cells (NPCs) 750 nM 2 days promoted Sox10+ oligodendroglia generation and increased differentiation of undifferentiated NPCs towards oligodendroglial fate Nat Commun. 2024 Nov 13;15(1):9837
FA patient fibroblasts 10 μM 24 hours To evaluate the protective effect of Dyclonine on FA patient fibroblasts under diamide-induced oxidative stress. Results showed Dyclonine significantly protected cells from diamide toxicity. Hum Mol Genet. 2014 Dec 20;23(25):6848-62

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Preterm birth brain injury (PBI) model Intranasal administration 5 mg/kg From P11 to P13, 3 times daily Promoted neural progenitor cell proliferation and oligodendroglial fate acquisition, with partial rescue of oligodendrocyte maturation Nat Commun. 2024 Nov 13;15(1):9837
Mice WT and TRPV3 KO mice Intradermal injection 1, 10, and 50 μM Single injection, 30 min observation Alleviation of TRPV3 hyperactivity-induced itching/scratching behavior Elife. 2021 Apr 20;10:e68128
FA-YG8 transgenic mice Friedreich's ataxia model Intraperitoneal or oral 1–10 mg/kg Once daily for 1 week To assess the effect of Dyclonine on FXN protein levels in the cerebellum of FA-YG8 mice. Results showed Dyclonine significantly increased FXN protein expression. Hum Mol Genet. 2014 Dec 20;23(25):6848-62

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03352700 Bowel Preparation Scale ... More >> the Amount of Air Bubble Adenoma Detection Rate Less << Phase 4 Not yet recruiting February 1, 2018 China ... More >> Changhai Hospital, Second Military Medical University Shanghai, China, 200433 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.07mL

0.61mL

0.31mL

15.34mL

3.07mL

1.53mL

30.69mL

6.14mL

3.07mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories